content

Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics

Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on...

Lilly to boost diabetes drug production with $450M factory investment

Eli Lilly and Co. plans to build a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Germany to expand its global parenteral product...

Chiesi, Haisco Partner on DPP1 Inhibitor for Respiratory Diseases

Chiesi Farmaceutici S.p.A, an international, research-focused biopharmaceuticals and healthcare group, and Haisco Pharmaceutical Group Co. Ltd entered a licensing agreement to develop, manufacture, and...

Cryoport’s CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express

Cryoport, Inc., a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine...

The Role of Robotics in Urological Surgeries: Precision, Outcomes, and Training

The advancements in technology and the desire for minimally invasive surgeries have converged to propel the field of robotic urological surgeries to the forefront. As...

Connected Devices Making Their Presence Felt In Pharma

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more...

Reference Approval Agencies Expanded By NPRA In Malaysia

The National Pharmaceutical Regulatory Agency- NPRAย of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read